ES
35
-4
BEN
42
-3
O
35
2
VLO
45
2
MCD
42
-4
DLTR
55
3
KEY
60
2
GPC
47
3
FSLR
40
-3
DTE
49
-5
EMR
50
2
TDC
62
3
DIS
64
2
WHR
43
3
SO
68
-2
EOG
39
-2
TGT
40
-2
EMC
80
-2
CL
50
-3
ADI
57
-6
ES
35
-4
BEN
42
-3
O
35
2
VLO
45
2
MCD
42
-4
DLTR
55
3
KEY
60
2
GPC
47
3
FSLR
40
-3
DTE
49
-5
EMR
50
2
TDC
62
3
DIS
64
2
WHR
43
3
SO
68
-2
EOG
39
-2
TGT
40
-2
EMC
80
-2
CL
50
-3
ADI
57
-6
Financhill
Back

Pacira BioSciences Stock Predictions

Pacaso has reserved the Nasdaq ticker PCSO and is offering shares at just $2.80 - but only until May 29.

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.*Pacaso recently received their ticker reservation with Nasdaq
Sell
33

PCRX
Pacira BioSciences

Last Price:
$25.77
Seasonality Move:
0.52%

7 Day Trial

ALL ACCESS PASS

$ 7

Disrupting a Trillion-Dollar Industry

Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.

Pacira BioSciences Stock Forecast

  • Over the next 52 weeks, Pacira BioSciences has on average historically risen by 18.2% based on the past 14 years of stock performance.
  • Pacira BioSciences has risen higher in 8 of those 14 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.14%
  • Is Pacira BioSciences Stock Undervalued?
    The current Pacira BioSciences [PCRX] share price is $26.07. The Score for PCRX is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • PCRX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Pacira BioSciences Stock Go Up Next Year?

  • Over the next 52 weeks, Pacira BioSciences has on average historically risen by 18.2% based on the past 14 years of stock performance.

Pacira BioSciences Stock Rating

Sell
33
Pacira BioSciences (PCRX) is a Sell

Is Pacira BioSciences overpriced?

  • Pacira BioSciences has risen higher in 8 of those 14 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.14%

Pacira BioSciences Stock Price History

Is PCRX stock going to rise?

  • The current trend is moderately bullish and PCRX is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
pacira.com

52-Week Data

52-Week High:
31.64
52-Week Low:
11.16

Prediction Charts

Market Cap:
1.2B
Price in USD:
26.07
Volume:
616.4K
Beta:
0.99

Technical Analysis

SMA50:
25.01
SMA100:
24.22
SMA200:
20.31
52-Wk Change:
-15.14%

Stock Predictions

  • Is Pacira BioSciences stock public?
    Yes, Pacira BioSciences is a publicly traded company.
  • What is the Pacira BioSciences stock quote today?
    The Pacira BioSciences stock price is 26.07 USD today.
  • How to buy Pacira BioSciences stock online?
    You can buy Pacira BioSciences shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-5 26.44 25.81 26.44 25.59
May-6 25.77 25.15 26.30 24.94
May-7 25.26 25.18 25.40 24.83
May-8 25.02 24.91 25.31 24.23
May-9 23.00 25.12 25.80 23.00
May-12 24.64 25.09 26.26 24.64
May-13 24.86 23.40 25.21 23.23
May-14 23.42 24.45 24.90 23.42
May-15 24.37 25.60 25.64 24.19
May-16 25.64 25.86 26.57 25.45
May-19 25.75 26.15 26.41 25.75
May-20 26.25 26.75 26.83 26.02
May-21 26.50 26.14 26.91 26.08
May-22 26.11 26.07 26.43 25.90

Pacira BioSciences Earnings

Pacira BioSciences Earnings Report: Per Share Pacira BioSciences Earnings Q1 Q2 Q3 and Q4 last year and next year.

Pacira BioSciences Forecast Revenue Growth

Pacira BioSciences Stock Analysis: Historical quarterly revenues per share for Pacira BioSciences and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, an increase next quarter of $0.13 per share, a decrease this year of $0.33 per share, and an increase next year of $0.47 per share.

* Pacira BioSciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.